Round Table Discussions: Analyzing the Latest Update from the FDA Review on the Comparability Guidelines
Time: 2:00 pm
day: Conference Day Two
Join us for an enlightening session as we delve into the recent update from the FDA on comparability guidelines and its potential implications for the evolving landscape of gene therapy development. In this session, we will explore diverse viewpoints from experts in the field, shedding light on the key facets of the FDA’s latest guidelines and how they may impact the gene therapy industry.
Explore diverse viewpoints on the FDA’s latest comparability guidelines and their potential impact on gene therapy development
Investigate the practicality and effectiveness of the FDA’s recent guidelines in streamlining the comparability assessment process
Navigate the relationship between the guidelines and the risk assessment strategies employed by industry stakeholders
Strategize how the FDA’s perspectives on comparability will evolve over time